Entry Detail



General Information

Database ID:exR0359489
RNA Name:AGO4
RNA Type:mRNA
Chromosome:chr1
Starnd:+
Coordinate:
Start Site(bp):35808016End Site(bp):35857890
External Links:ENSG00000134698



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ADAM19
chr5
157395534
157575775
-
MT1G
chr16
56666731
56668065
-
POLD2
chr7
44114681
44124358
-
UBXN6
chr19
4444999
4457794
-
RPLP2
chr11
809965
812880
+
TATDN2
chr3
10248023
10281218
+
PTGES2
chr9
128120693
128128462
-
VAMP3
chr1
7771296
7781432
+
CBFA2T2
chr20
33490075
33650036
+
TMEM132A
chr11
60924463
60937159
+
MT-CO3
chrMT
9207
9990
+
TRIM73
chr7
75395063
75410996
+
SFPQ
chr1
35176378
35193145
-
PMEL
chr12
55954105
55973317
-
RPL37
chr5
40825262
40835222
-
GATA2
chr3
128479427
128493201
-
PTMA
chr2
231706895
231713541
+
SRGN
chr10
69088103
69104805
+
YBX1
chr1
42682418
42703805
+
SLC38A2
chr12
46358188
46372773
-
HNRNPF
chr10
43385617
43409166
-
ANKH
chr5
14704800
14871778
-
AGO3
chr1
35930718
36072500
+
OSBPL8
chr12
76351797
76559809
-
DDX5
chr17
64498254
64508199
-
SDF4
chr1
1216908
1232067
-
XPO1
chr2
61477849
61538626
-
LGMN
chr14
92703807
92748679
-
ARL8B
chr3
5122245
5180912
+
GGCT
chr7
30496621
30504841
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC124944.3
chr3
195900986
195903417
+
NEAT1
chr11
65422774
65445540
+
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.